Klassen Preston

Track

Insider profile

Klassen Preston's trades of Regulus Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
117.54
Quantity 19,421 +36.5%
Value US$4,210,030
Transaction date
Sale
Price
467.25
Quantity 18,579 -15.9%
Value US$1,041,828
Transaction date
Sale
Price
0.51
Quantity 1,173 -0.1%
Value US$593
Transaction date
Sale
Price
0.50
Quantity 43,575 -4.5%
Value US$21,879
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-04 2025-06-03
B Purchase
19,421 +36.5%
117.54
US$4,210,030 		19,421 +36.5% 117.54 US$4,210,030
2025-01-15 2025-01-13
PlS Planned sale
12,783 -21.1%
312.56
US$1,599,442 		12,783 -21.1% 312.56 US$1,599,442
2023-01-27 2023-01-26
S Sale
18,579 -15.9%
467.25
US$1,041,828 		18,579 -15.9% 467.25 US$1,041,828
2022-04-20 2022-04-19
S Sale
1,173 -0.1%
0.51
US$593 		1,173 -0.1% 0.51 US$593
2022-04-20 2022-04-19
S Sale
43,575 -4.5%
0.50
US$21,879 		43,575 -4.5% 0.50 US$21,879
2019-01-08 2019-01-08
PlS Planned sale
3,000 -100.0%
44.00
US$132,000 		3,000 -100.0% 44.00 US$132,000
2019-01-08 2019-01-07
PlS Planned sale
400 -100.0%
42.32
US$16,927 		400 -100.0% 42.32 US$16,927
2019-01-08 2019-01-07
PlS Planned sale
15,600 -97.5%
41.68
US$650,139 		15,600 -97.5% 41.68 US$650,139